Location History:
- Germantown, MD (US) (2012 - 2014)
- Philadelphia, PA (US) (2018)
- Rockville, MD (US) (2017 - 2021)
- New York, NY (US) (2023)
Company Filing History:
5 out of 68 
4 out of 2,597 
3 out of 509 
Years Active: 2012-2025
Title: Dominick J Laddy: Innovator in Vaccine Development
Introduction
Dominick J Laddy is a prominent inventor based in Rockville, MD (US). He has made significant contributions to the field of vaccine development, particularly in the fight against tuberculosis. With a total of 9 patents to his name, Laddy's work has the potential to impact public health on a global scale.
Latest Patents
Laddy's latest patents include innovative approaches to using recombinant cytomegalovirus vectors as vaccines for tuberculosis. These patents provide cytomegalovirus vectors encoding fusion proteins comprising Mycobacterium tuberculosis (Mtb) antigens, nucleic acid molecules encoding the same, and methods for eliciting an immune response against tuberculosis. Another notable patent focuses on tuberculosis antigen cassettes, which also provide fusion proteins comprising Mtb antigens and methods for eliciting an immune response.
Career Highlights
Throughout his career, Dominick J Laddy has worked with esteemed organizations such as the University of Pennsylvania and the International Aids Vaccine Initiative. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Laddy's notable coworkers include Thomas G Evans and David B Weiner. Their collaborative efforts have further advanced the research and development of effective vaccines.
Conclusion
Dominick J Laddy's innovative work in vaccine development, particularly against tuberculosis, showcases his dedication to improving global health. His contributions through patents and collaborations highlight the importance of research in combating infectious diseases.